JOHNNY IQBAL: Open Payments
NPI 1295007714 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,265 in 99 payments from 34 companies in 2025. Trend: 2023 $2,605 · 2024 $2,475 · 2025 $2,265
Food & beverage: $2,165Education: $100
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $235 |
| Merck Sharp & Dohme LLC | 7 | $180 |
| E.R. Squibb & Sons, L.L.C. | 9 | $175 |
| Celgene Corporation | 6 | $161 |
| Daiichi Sankyo Inc. | 7 | $149 |
| GlaxoSmithKline, LLC. | 5 | $120 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $111 |
| AstraZeneca Pharmaceuticals LP | 5 | $109 |
| SEAGEN INC. | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
Products named: OPDIVO, PADCEV, KEYTRUDA, Enhertu, Nubeqa, OJJAARA, REBLOZYL, BESREMI.
Industry payments across FL — which companies pay providers there.
